Healthy volunteers help map normal pancreatic fluid
NCT ID NCT07285863
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to collect and analyze pancreatic fluid from 24 healthy adults after giving them a synthetic hormone called secretin. The secretin is injected during an endoscopic ultrasound to stimulate the pancreas to release fluid, which is then collected from the duodenum. Researchers will measure levels of bicarbonate, sodium, potassium, and chloride to better understand normal pancreatic fluid composition. This knowledge may help improve diagnosis and monitoring of pancreatic diseases like chronic pancreatitis.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
human secretin (CHIROSTIM)
What this could lead to
If successful, this study could help establish normal ranges for pancreatic fluid components, improving diagnosis of pancreatic conditions like chronic pancreatitis.
What could go wrong
This is a small, early-phase study in healthy volunteers, not a treatment trial. Results may not directly apply to patients with pancreatic disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EXOCRINE PANCREATIC INSUFFICIENCY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Mayo Clinic in Rochester
RECRUITINGRochester, Minnesota, 55905, United States
Contact Phone: •••-•••-••••
Contact